DiaMedica Therapeutics Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
DiaMedica Therapeutics Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • DiaMedica Therapeutics Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $298K, a 19.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $298K -$74K -19.9% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $317K -$73K -18.7% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $336K -$71K -17.4% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $354K -$70K -16.5% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $372K -$69K -15.6% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $390K +$379K +3445% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $407K +$381K +1465% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $424K +$382K +910% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $441K +$384K +674% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $11K -$61K -84.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $26K -$60K -69.8% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $42K -$58K -58% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $57K -$57K -50% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $72K -$55K -43.3% Jun 30, 2021 10-Q 2021-08-11
Q1 2021 $86K -$54K -38.6% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $100K -$53K -34.6% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $114K -$51K -30.9% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $127K -$50K -28.2% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $140K -$49K -25.9% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $153K Dec 31, 2019 10-K 2021-03-10
Q3 2019 $165K Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $177K Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $189K Mar 31, 2019 10-Q 2019-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.